Is Gsk Stock a good buy in 2026, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NYSE: GSK) stock is to Hold GSK stock.
Out of 1 analyst, 0 (0%) are recommending GSK as a Strong Buy, 0 (0%) are recommending GSK as a Buy, 1 (100%) are recommending GSK as a Hold, 0 (0%) are recommending GSK as a Sell, and 0 (0%) are recommending GSK as a Strong Sell.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.